• Explore /
  • Poster
  • / A pilot phase II trial of neoadjuvant camrelizumab plus nab-paclitaxel and cisplatin (NeoCPC) for locoregionally advanced, resectable squamous cell carcinoma of the head and neck.

A pilot phase II trial of neoadjuvant camrelizumab plus nab-paclitaxel and cisplatin (NeoCPC) for locoregionally advanced, resectable squamous cell carcinoma of the head and neck.

Abstract Poster

Authors

null

Di Wu

Sun Yat-Sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China, Guangzhou, Guangdong, China

Di Wu , Yong Li , Peng-Fei Xu , Xinrui Zhang , Hongsheng Lin , Yin Li , Qi Fang , Fei Cao , Yong Su , Li-Xia Lu , Yizhuo Li , Zheng Zhao , Xiaoyu Hong , Guohong Li , Honghong Yan , Yunyun Fan , Lei Chen , Zhiming Li , Xuekui Liu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT04826679

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6069)

DOI

10.1200/JCO.2023.41.16_suppl.6069

Abstract #

6069

Poster Bd #

61

Abstract Disclosures

Similar Posters

First Author: Lei Liu

First Author: Michal Sternschuss

First Author: Jing Chen

First Author: Hailiang Zhang